Biotechnology News

Tue, 2014-03-25 12:04

WASHINGTON--(BUSINESS WIRE)--BIO today reaffirmed and broadened its long-standing commitment to improving human health through the development of innovative therapies by releasing Principles on Clinical Trial Data Sharing.

Tue, 2014-03-25 12:04

NEW YORK--(BUSINESS WIRE)--Actinium Pharmaceuticals will commence trading on the NYSE MKT on March 26, 2014 and will retain its symbol: ATNM.

Tue, 2014-03-25 12:04

FAIRFAX, Va.--(BUSINESS WIRE)--ACT-IAC today announced the winning programs and overall winner for the 14th annual Excellence.Gov Awards. The event honors the best of government information technology (IT) programs.

Tue, 2014-03-25 12:04

JUPITER, Fla.--(BUSINESS WIRE)--BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTCBB:BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, today announced that it has...

Tue, 2014-03-25 12:04

LEXINGTON, Mass.--(BUSINESS WIRE)--SynapDx Corporation today announced that founder and CEO Stanley Lapidus was inducted to the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows.

Tue, 2014-03-25 12:04

BOSTON & GENEVA--(BUSINESS WIRE)--The new FDA Roadmap App from patient-driven eData innovators PHT Corporation is the 1st mobile app to help sponsors navigate the FDA Roadmap to Patient-Focused Outcome Measurement in Clinical Trials.

Tue, 2014-03-25 12:04

AUSTIN, Texas--(BUSINESS WIRE)--The Austin Technology Council announced the appointment of Gary Sabins and Kevin Callahan to Chairman and Vice Chairman, respectively, of the ATC Board of Directors.

Tue, 2014-03-25 12:04

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Chief Executive Officer Michael D. West, PhD will present at...

Tue, 2014-03-25 12:04

BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced the appointment of Glenn A. Eisenberg as Executive Vice President and Chief Financial Officer, effective June 16, 2014. Brad...

Tue, 2014-03-25 12:04

BURLINGAME, Calif.--(BUSINESS WIRE)--Igenica Biotherapeutics, a company focused on the discovery and development of innovative antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer, announced today that Mary Haak-Frendscho,...

Tue, 2014-03-25 12:04

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Voyager Therapeutics, a gene therapy company developing life-changing treatments for fatal and debilitating diseases of the central nervous system (CNS), today announced that Bernard Ravina, M.D., M.S.C.E., has...

Tue, 2014-03-25 12:04

BOSTON--(BUSINESS WIRE)--MDGBoston, the New England medical device industry’s professional network, announced today that it will sponsor a forum on Wednesday, April 2, 2014: “Cardiac Disease: From Algorithms to Products,” from 5:30—8:00 p.m. at...

Tue, 2014-03-25 12:04

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (NASDAQ: CERS) announced today that Dr. Frank Witney, president and chief executive officer of Affymetrix, has joined its board of directors and the compensation committee. Dr. Witney joins the...

Tue, 2014-03-25 12:04

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today announced the appointment...

Tue, 2014-03-25 12:04

BOULDER, Colo.--(BUSINESS WIRE)--miRagen announces drug development veteran Dr. David Rodman has joined the executive team. Rodman will lead the discovery and clinical development of miRagen’s microRNA (miRNA)-based therapeutics.

Tue, 2014-03-25 12:04

HAWTHORNE, Calif. & LEXINGTON, Mass.--(BUSINESS WIRE)--BioDiscovery, Inc., and N-of-One, the leading provider of molecular interpretation, today announced a partnership to jointly provide integrated genomic analysis interpretation solutions...

Tue, 2014-03-25 12:04

WOBURN, Mass.--(BUSINESS WIRE)--Courtagen Life Sciences announced today an agreement with Raptor Pharmaceuticals Inc. to provide genetic testing in the clinical trial for RP103 as a potential treatment for Leigh syndrome and other mitochondrial...

Tue, 2014-03-25 12:04

CAMBRIDGE, Mass.--(BUSINESS WIRE)--BIND Therapeutics Reports Fourth Quarter and Full Year 2013 Financial Results

Tue, 2014-03-25 08:03

IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc., a developer of novel implantable neuromodulation technology, announced today that it has completed a $32.6 million Series A preferred stock financing. Axonics holds an...

Tue, 2014-03-25 08:03

BEDMINSTER, N.J. & RESEARCH TRIANGLE PARK, N.C. & NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of...

Tue, 2014-03-25 08:03

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced that the Company will present data at the upcoming American...

Tue, 2014-03-25 08:03

NEW YORK--(BUSINESS WIRE)--Actinium Pharmaceuticals will be presenting at BioCentury 21st Annual Future Leaders in the Biotech Industry Conference on March 28 in NYC. The presentation will be webcast.

Tue, 2014-03-25 08:03

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) today announced that the European Commission has approved COMETRIQ® (cabozantinib) for the treatment of adult patients with progressive, unresectable locally advanced or...

Tue, 2014-03-25 04:08

PARIS & SAN FRANCISCO--(BUSINESS WIRE)--SpineGuard (FR0011464452 – ALSGD), an innovative company that designs, develops and markets disposable bone-monitoring devices intended to make spine surgery safer, reported today its full-year 2013...

Tue, 2014-03-25 04:08

STRASBOURG, France--(BUSINESS WIRE)--Regulatory News: Not for distribution in or into Canada, Japan or Australia.This communication is not offering material and is for information purposes only. Transgene SA (Paris:TNG) (Euronext Paris:...

Mon, 2014-03-24 20:02

NEW YORK--(BUSINESS WIRE)--Actinium Pharmaceuticals will be listing on the NYSE MKT on March 26, 2014, having been approved for listing. Its stock symbol will remain the same, "ATNM" as the company achieves another milestone.

Mon, 2014-03-24 20:02

NEW YORK--(BUSINESS WIRE)--Actinium Pharmaceuticals announced that the first patient was successfully treated with Actimab-A drug candidate made with a new lot of Lintuzumab, the antibody providing the backbone of Actimab-A.

Mon, 2014-03-24 20:02

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix International N.V. (NASDAQ:OFIX) will hold a conference call and webcast on Thursday, March 27, 2014 at 8:30 a.m. ET to discuss its financial results for the year ended December 31, 2013, which it...

Mon, 2014-03-24 20:02

WASHINGTON--(BUSINESS WIRE)--A group of biofuel trade organizations today sent a letter to Senate Finance Committee Chairman Ron Wyden (D-Ore.) and Ranking Member Orrin Hatch (R-Utah) encouraging extension of critical advanced biofuel tax...

Mon, 2014-03-24 20:02

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. ("ACT"; OTCBB: ACTC), a leader in the field of regenerative medicine, and its collaborators reported today that it has discovered a new method to generate a potent and...

Mon, 2014-03-24 20:02

WATERTOWN, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leader in the development of RNAi-based therapeutics, will report its fourth quarter 2013 financial results on March 27, 2014. Dicerna will host a conference call...

Mon, 2014-03-24 20:02

SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) announced on Friday, March 21, 2014 that the U.S. Food and Drug Administration (FDA) has approved OTEZLA® (apremilast), the Company’s oral, selective inhibitor of phosphodiesterase...

Mon, 2014-03-24 16:04

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea presents data at World Vaccine Congress for ongoing Ph.1/2a study of GEN-003 for HSV-2 showing highly significant reductions in clinical symptoms and rate of viral shedding at 6 months.

Mon, 2014-03-24 16:04

WASHINGTON--(BUSINESS WIRE)--David Brancaccio, host of Marketplace Morning Report, will deliver opening remarks at the Global Markets Forum as well as moderate the Scientific American Super Session at BIO 2014 in San Diego.

Mon, 2014-03-24 16:04

VILLEJUIF & EVRY, France--(BUSINESS WIRE)--IntegraGen and Gustave Roussy announce the creation of the first high-throughput, large-scale, personalized medicine clinical sequencing platform for oncology patients to aid in targeted therapeutics...

Mon, 2014-03-24 16:04

PITTSBURGH--(BUSINESS WIRE)--A match-driven TrueAllele® workflow is a DNA hit in Kern County, California. Most crime labs manually interpret data from mixtures of two or more people. Their painstaking analysis often yields no useful result, and...

Mon, 2014-03-24 12:04

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Wake Forest University School of Business Biotech Conference and Case Competition awarded first place during a gala held March 22 in downtown Winston-Salem.

Mon, 2014-03-24 12:04

WASHINGTON--(BUSINESS WIRE)--Advanced biofuel producers will discuss the industry’s progress toward commercial reality during breakout sessions at the World Congress on Industrial Biotechnology, BIO announced today.

Mon, 2014-03-24 12:04

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Monsanto announced today the creation of Preceres LLC with founders Daniel Anderson Ph.D., Associate Professor in the Department of Chemical Engineering and the Institute of Medical Engineering and Science at...

Mon, 2014-03-24 12:04

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, presented scientific posters about new products

Mon, 2014-03-24 12:04

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Welch Allyn cardiopulmonary devices now interface with one of Canada’s leading national electronic medical record (EMR) software solutions, Accuro®EMR.

Mon, 2014-03-24 12:04

SAN DIEGO--(BUSINESS WIRE)--DermTech Releases Validation Data and Announces CLIA Licensure

Mon, 2014-03-24 12:04

NEW YORK--(BUSINESS WIRE)--SeeThruEquity, a leading New York City based independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has issued a note on Pressure BioSciences,...

Mon, 2014-03-24 12:04

CAESAREA, Israel--(BUSINESS WIRE)--Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM: MZOR), a developer of innovative guidance systems and complementary products, announced today that it has received an order for a Renaissance system from AB Medica SpA...

Mon, 2014-03-24 12:04

INGELHEIM, Germany--(BUSINESS WIRE)--For media outside of the US, the UK & Canada only Boehringer Ingelheim has today announced that new findings from ongoing Pradaxa® (dabigatran etexilate) research will be presented during the American...

Mon, 2014-03-24 12:04

SEATTLE--(BUSINESS WIRE)--BEAT BioTherapeutics Corp. (BEATBio) announced today the appointment of Sam L. Teichman, MD, FACC, FESC, FACP, as Chief Medical Officer (CMO) and Director. BEATBio is developing BB-R12, a novel biological therapy with...

Mon, 2014-03-24 12:04

CHELSEA, Mass.--(BUSINESS WIRE)--Civitas Therapeutics will participate in the 21st Annual Future Leaders in the Biotech Industry Conference with a presentation by Pres. & CEO Mark Iwicki, on March 28, 2014.

Mon, 2014-03-24 12:04

PLYMOUTH, Mich.--(BUSINESS WIRE)--Esperion Therapeutics, Inc. (NASDAQ: ESPR), a clinical-stage biopharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol (LDL-C) lowering...